PHILADELPHIA, March 5, 2019 /PRNewswire/ -- Carisma Therapeutics Inc., a preclinical-stage biopharmaceutical companyfocused on discovering and developing innovative immunotherapies based on chimeric antigen receptor macrophages, today announced that the Company's management will present at three upcoming investor and industry conferences:
The Alliance for Regenerative Medicine Cell & Gene Investment Day is filmed and livestreamed from the meeting website at http://arminvestorday.com/webcast/.
About Carisma Therapeutics Inc.
Carisma Therapeutics Inc. is biopharmaceutical company bringing the power of adoptive cellular immunotherapy to solid tumor patients through a differentiated platform using chimeric antigen receptor macrophages. Carisma Therapeutics is headquartered in Philadelphia, PA. For more information, please see the Company's website at https://carismatx.com/.
Deirdre Purdy for Carisma TherapeuticsDeirdre@0to5.com 914-819-7870
View original content:http://www.prnewswire.com/news-releases/carisma-therapeutics-announces-upcoming-conference-participation-300806800.html
SOURCE Carisma Therapeutics Inc.
Subscribe to our Free Newsletters!